High-activity halophilic xylanase as well as coding gene, expression system and application thereof
By isolating and genetically modified from halophilic xylanase bacteria, high-viability, acid-base-resistant and halophilic xylanases are obtained, which solves the problem of insufficient catalytic performance of the existing GH11 xylanase in high-salt environments. , achieved significant improvement in high-salt environment, and was suitable for high-salt food processing and aquatic feed production and other fields.
Patent Information
- Application Number
- CN202411250362.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-06
- Publication Date
- 2024-11-22
AI Technical Summary
The existing GH11 xylanase has insufficient catalytic performance and thermal stability in high-salt environments, making it difficult to meet the needs of high-salt and marine food processing, aquatic feed production, industrial wastewater treatment and other fields.
By isolating halophilic xylanase bacteria from the soil, obtaining its encoding genes and undergoing molecular modification, recombinantly expressing high-viability, acid-base-resistant, and halophilic xylanases, specifically including modification of amino acid sequences and gene recombination. , and form derivative proteins that significantly enhance enzyme activity.
The enzyme activity is significantly enhanced under the conditions of 0.25-3M NaCl, especially under 2M NaCl, the enzyme activity is increased by more than 3 times. It can stabilize the hydrolysis of xylan into xyoligosaccharides. It is suitable for the preparation of high-quality XOS and has a high-salt environment. significant advantages.
Smart Images

Figure CN118995676A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of enzyme engineering, and in particular to a high-activity halophilic xylanase and a coding gene, an expression system and application thereof. Background Art
[0002] Xylanase, also known as endo-β-1,4-xylanase, is a protein that catalyzes the hydrolysis of xylan. Based on the similarity of structure and function, most xylanases belong to glycoside hydrolase family 10 or 11. Xylanases can be produced by a variety of microorganisms, such as bacteria, fungi, yeast, seaweed, etc. Since xylan is the main component of hemicellulose and the most abundant carbohydrate after cellulose, accounting for one-third of the earth's recyclable organic carbon, its conversion and utilization are of great significance. GH11 xylanase is the most typical xylanase, which has substrate specificity for xylan and contains only one catalytic domain. Xylanases have been widely used in food, animal feed, paper and pulping, and biofuel industries, among which hydrolysis of xylan to produce prebiotic xylo-oligosaccharides (XOS) is an important application in the food field. At present, GH11 xylanases with different properties, especially salt-tolerant xylanases, have become an urgent need in the fields of high-salt and marine food processing, aquatic feed production, industrial wastewater treatment, saline-alkali soil improvement, and global carbon cycle.
[0003] Catalytic activity and stability are the two most critical characteristics of all enzyme proteins. Improving the catalytic performance and thermal stability of GH11 xylanase on the basis of salt tolerance has greater practical value. Directed evolution and rational design of GH11 xylanase engineering have attracted more and more attention. Many directed evolution methods, including DNA recombination, error-prone polymerase chain reaction, saturation mutagenesis and differential mutagenesis, have been used to design xylanases, but this strategy is time-consuming and labor-intensive due to the large workload in the screening process. Rational design based on structure and function is more effective for the molecular modification of xylanase. The replacement of some key amino acids often greatly changes the function of the protein. Summary of the invention
[0004] In view of this, the embodiments of the present application provide a high-activity halophilic xylanase and its application, so as to provide a high-activity halophilic GH11 xylanase protein, and use the high-activity halophilic GH11 xylanase protein to enzymatically convert xylans from different sources.
[0005] The present application provides the following technical solution: a high-activity halophilic xylanase, which is the following protein (a) or (b):
[0006] (a) a protein consisting of the amino acid sequence shown in SEQ ID NO.1;
[0007] (b) A derivative protein having a higher xylanase activity than the protein in (a) by replacing and / or deleting and / or adding one or more amino acid residues of the amino acid residues shown in SEQ ID NO.1.
[0008] Furthermore, SEQ ID NO. 1 consists of 185 amino acids and has a molecular weight of approximately 20 kDa.
[0009] Another aspect of the present invention provides a gene encoding the above-mentioned high-activity halophilic xylanase.
[0010] According to one embodiment of the present invention, the nucleotide sequence of the encoding gene is a DNA molecule shown in SEQ ID NO.2.
[0011] According to one embodiment of the present invention, the nucleotide identity between the coding gene and the DNA molecule shown in SEQ ID NO.2 is greater than 90%.
[0012] Another aspect of the present invention provides a recombinant vector comprising the above-mentioned encoding gene.
[0013] Another aspect of the present invention provides a transgenic cell line comprising the above-mentioned encoding gene.
[0014] Another aspect of the present invention provides a recombinant bacterium comprising the above-mentioned encoding gene.
[0015] Another aspect of the present invention provides the use of the above-mentioned high-activity halophilic xylanase, the above-mentioned encoding gene, the above-mentioned recombinant vector, the above-mentioned transgenic cell line, and the above-mentioned recombinant bacteria in hydrolyzing xylan.
[0016] According to one embodiment of the present invention, the xylan hydrolysis reaction is carried out in the presence of 0.25-3 M NaCl.
[0017] Compared with the prior art, the beneficial effects achieved by at least one of the above technical solutions adopted in the embodiments of this specification include at least: the embodiment of the present invention separates a bacterium producing halophilic xylanase from the soil, and obtains the coding gene Xyn of the halophilic xylanase by molecular biology and genetic engineering methods. st , and the gene was molecularly modified and recombinantly expressed. The recombinant enzyme has the characteristics of high activity, acid and alkali resistance, and salt love. The enzyme activity is stable in the pH range of 5-9. NaCl within 0.25-3M has a significant improvement on the enzyme activity, especially 2M NaCl can increase the enzyme activity by more than 3 times. In addition, the hydrolysis products of xylan by the enzyme are a series of xylooligosaccharides from xylobiose to xylopentose, which can be used to prepare high-quality XOS. Therefore, xylanase Xyn st The characteristics of acid and alkali resistance, salt affinity and high activity of its derivative proteins have significant advantages, especially in various high-salt environments. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present application. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0019] Figure 1A A schematic diagram of a mutant in an embodiment of the present invention; Figure 1B Xylanase Xyn in the present invention st Schematic diagram of the enzyme activities of its 11 mutants;
[0020] Figure 2 Xylanase Xyn in the present invention st and SDS-PAGE electrophoresis of mutant W6F / Q7H;
[0021] Figure 3A Xylanase Xyn in the present invention st and pH properties of mutant W6F / Q7H; Figure 3B Xylanase Xyn in the present invention st and the enzyme activity stability of mutant W6F / Q7H under optimal pH conditions;
[0022] Figure 4A Xylanase Xyn in the present invention st and the temperature characteristics of mutant W6F / Q7H; Figure 4B Xylanase Xyn in the present invention st Stability at different temperatures; Figure 4C They are respectively the stability of the xylanase mutant W6F / Q7H in the embodiment of the present invention at different temperatures;
[0023] Figure 5A Xylanase Xyn in the present invention st and a schematic diagram of the tolerance of mutant W6F / Q7H to NaCl; Figure 5B Xylanase Xyn in the present invention st and the enzyme activity stability of mutant W6F / Q7H at different NaCl concentrations;
[0024] Fig. 6A Xylanase Xyn in the embodiment of the present invention st and thin layer chromatogram of hydrolyzate after mutant W6F / Q7H hydrolyzed bagasse xylan; Figure 6B Xylanase Xyn in the present invention stAnd thin layer chromatogram of the hydrolyzate after mutant W6F / Q7H hydrolyzed wheat straw xylan. DETAILED DESCRIPTION
[0025] The embodiments of the present application are described in detail below with reference to the accompanying drawings.
[0026] The following describes the implementation methods of the present application through specific examples, and those skilled in the art can easily understand other advantages and effects of the present application from the contents disclosed in this specification. Obviously, the described embodiments are only a part of the embodiments of the present application, rather than all the embodiments. The present application can also be implemented or applied through other different specific implementation methods, and the details in this specification can also be modified or changed in various ways based on different viewpoints and applications without departing from the spirit of the present application. It should be noted that, in the absence of conflict, the following embodiments and the features in the embodiments can be combined with each other. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in the field without making creative work belong to the scope of protection of the present application.
[0027] The embodiment of the present invention provides a high-activity halophilic xylanase, which is a protein of (a) or (b): (a) a protein consisting of the amino acid sequence shown in SEQ ID NO.1; (b) a derivative protein having a higher activity than the protein xylanase of (a) by replacing and / or deleting and / or adding one or more amino acid residues of the amino acid residues shown in SEQ ID NO.1. The endoxylanase of the present invention has a high specific activity, good acid-base stability, and is enhanced by high salt. It has a good application prospect in a high-salt environment, such as high-salt food processing, aquatic feed production, saline wastewater treatment, and saline-alkali land fertility improvement.
[0028] The protein of the embodiment of the present invention can be cloned from an organism or artificially synthesized. SEQ ID NO.1 in the sequence table consists of 185 amino acids and has a molecular weight of about 20 kDa. The coding gene of the high-activity halophilic xylanase can be any of the following DNA molecules: 1) the DNA molecule shown in SEQ ID NO.2 in the sequence table; 2) a DNA molecule having more than 90% homology with the DNA molecule shown in SEQ ID NO.2 and encoding a xylanase function.
[0029] Sequence Listing
[0030] Sequence 1 (SEQ ID NO.1), protein sequence, 185aa
[0031] ANTDYWQNWTDGGGTVNAVNGSGGNYSVNWSNTGNFVVGKGWTTGSPFRTINYNAGVWAPNGNAYLTLYGWTRSPLIEYYVVDSWGTYRPTGTY
[0032] KGTVYSDGGTYDVYTTTRYDAPSIDG
[0033] DKTTFTQYWSVRQSKRPTGSNATITFSNHVNAWKRYGMNLGSNWSYQVL
[0034] ATEGYQSSGSS NVTVW
[0035] Sequence 2 (SEQ ID NO.2), DNA sequence, 558 bp
[0036] GCTAACACAGACTACTGGCAAAATTGGACTGATGGGGGCGGAACAGTAAACGCTGTCAATGGGTCTGGCGGGAATTACAGTGTGAATTGGTCTAATACCGGGAATTTCGTTGTTGGTAAAGGTTGGACTACAGGTTCGCCATTTAGGACGATAAACTATAATGCCGGAGTTTGGGCGCCGAATGGCAATGCATATTTGACTTTATATGGTTGGACGCGATCACCCCTCATAGAATATTATGTAGTGGATTCATGGGGTACTTATAGACCTACTGGAACGTATAAAGGTACGGTTTACAGTGATGGGGGTACATATGACGTGTACACAACTACACGTTATGATGCACCTTCCATTGATGGCGATAAAACTACTTTTACGCAGTACTGGAGTGTTCGCCAGTCGAAGAGACCAACTGGAAGCAACGCTACAATCACTTTCAGCAATCACGTTAACGCATGGAAGAGATATGGGATGAATCTGGGTAGTAATTGGTCTTACCAAGTCTTAGCGACAGAGGGATATCAAAGTAGTGGAAGTTCTAACGTAACAGTGTGGTAA
[0037] The experimental methods used in the following examples are all conventional methods unless otherwise specified.
[0038] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0039] Example 1: Identification and acquisition of xylanase and its encoding gene
[0040] 1. Screening and identification of xylanase and its encoding gene
[0041] A xylanase-secreting bacterium was isolated from the soil. The comparison of its 16s rRNA gene sequence showed that it had a 99% similarity with several Bacillus sp. and was tentatively named Bacillus sp.SC1.
[0042] A single colony of SC1 was inoculated into LB liquid medium, and fermented at 150 rpm and 30°C for 24 hours, and then the supernatant was collected by centrifugation at 10,000 rpm for 5 minutes. 65% ammonium sulfate was added to the supernatant, and the protein was precipitated by stirring, and then purified by gel filtration.
[0043] The purified protein was loaded for SDS-PAGE electrophoresis, and the electrophoresis bands were cut for LC-MS / MS identification.
[0044] The peptide sequences were matched and compared according to mass spectrometry, indicating that the protein in one of the bands might be an endoxylanase, which had 41% amino acid sequence identity with the glycoside hydrolase WP_101863413 of the GH11 family of Bacillus halotolerans.
[0045] Bioinformatics analysis showed that WP_101863413 had 213 amino acid residues, was highly homologous to Bacillus GH11 family xylanase XynA, and contained a 28 amino acid protein signal peptide at the N-terminus.
[0046] 2. Obtaining xylanase encoding genes
[0047] Using Bacillus sp. SC1 genomic DNA as a template and the gene sequence corresponding to the mature protein of WP_101863413 as a reference, the following primers were designed: forward primer 5'-GCGCTAACACAGACTAC TGGC-3'; reverse primer 5'-TTACCACACTGTTACGTTAG-3' for PCR amplification. The PCR amplification conditions were as follows: pre-denaturation at 95°C for 5 min, then 95°C for 30 s, 55°C for 30 s, and 72°C for 90 s, for a total of 35 cycles; finally, extension at 72°C for 5 min to obtain a PCR product of 558 bp.
[0048] The PCR product was excised from the gel, recovered and purified, and double-digested with Hind III and Xho I. The digested product was ligated with the pET28a vector digested with the same enzymes using T4 ligase at 4°C overnight. The ligated product was transformed into Escherichia coli DH5α competent cells to obtain recombinant bacteria.
[0049] The plasmid of the recombinant bacteria was sequenced and verified. The results showed that the PCR product in the plasmid had the nucleotide sequence 1 (SEQ ID NO.1) in the sequence table. The gene of the PCR product was named Xyn st The amino acid sequence of the protein encoded by the gene is sequence 1 in the sequence list. Sequence 2 (SEQ ID NO. 2) in the sequence list was inserted between the Hind III and Xho I sites of pET28a and named pET28a-Xyn st .
[0050] Sequence 2 can also be chemically synthesized using the above method to obtain pET28a-Xyn st .
[0051] Example 2: Molecular modification and screening of xylanase genes
[0052] 1. Molecular modification of xylanase encoding genes
[0053] To further improve Xyn st The stability and catalytic activity of Xyn were simulated using Autodock software. st Molecular docking with xylohexose and xylotriose was performed to identify eight key sites (Y5, W6, Q7, W9, Y65, R49, R112, and W129), and saturation mutagenesis was performed.
[0054] Primers were designed using SnapGene software and point mutations were introduced using primers. st The full length of the plasmid was amplified by PCR using the template, and the amplification conditions were: 95°C for 5 min, 95°C for 30 s, 56°C for 7 min, and 72°C for 5 min. Denaturation-annealing-extension, a total of 35 cycles; and finally extension at 72°C for 5 min to obtain the complete plasmid.
[0055] The PCR product was recovered using a commercial column DNA purification kit. In order to remove template interference in subsequent screening, the PCR product was treated with Dpn I. The reaction conditions were: 37°C for 30 min, 80°C for 30 min.
[0056] 2. Screening of high-activity xylanase encoding genes
[0057] 5 μL (concentration of 50 ng / μL) of PCR product was introduced into 100 μL of E. coli BL21 competent cells, and then spread on LB solid medium containing kanamycin and cultured at 37° C. for 14 h.
[0058] Pick a single colony with a sterile toothpick, transfer it to a sterile 96-well deep-well plate (0.6 mL of liquid LB containing kanamycin per well), culture at 37°C and 180 r / min until OD600 reaches about 0.6, add IPTG at a working concentration of 1 mM, and induce expression at 25°C (>2 h).
[0059] Use a spray gun to transfer 200 μL of the cultured bacterial solution to a 96-well PCR plate, centrifuge at 5000 r / min for 10 min, pour off the supernatant, add 100 μL of distilled water to each well, vortex to mix, cover the 96-well PCR plate tightly, and place the plate in a non-contact ultrasonic cell disruptor for cell disruption (4°C, 30 min, 100% power, work 10 s and stop 10 s). The disrupted liquid is the crude enzyme solution.
[0060] Transfer 50 μL of crude enzyme solution to a new 96-well PCR plate, add 100 μL of beech xylan substrate solution (10 mg / mL), place in a preheated vibrating metal bath, react at 1600 r / min, and at different temperatures (65°C, 75°C, 80°C) for 10 min. After the reaction, immediately add 50 μL of DNS reagent, and place the 96-well PCR plate in a PCR instrument and heat at 99°C for 15 min.
[0061] After cooling to room temperature, 50 μL was added to a 96-well microplate containing 150 μL of distilled water and the OD540 was measured using a microplate reader. Mutants with significantly higher OD540 than the starting strain were transferred to culture, and the above screening was repeated three times to determine whether the positive mutant strain with increased OD value could be stably inherited, and then sequenced to confirm the amino acid mutation site.
[0062] like Figure 1A As shown, highly active mutants can be quickly screened using a 96-well plate, as evidenced by obvious differences in color depth in different wells. Figure 1A The dark grey dots in the figure represent the starting protein Xyn st , light grey dots represent positive mutants with significantly increased absorbance values, and black dots represent insignificant or negative mutants; Figure 1B Xylanase Xyn st The enzyme activity levels of its 11 mutants at different temperatures.
[0063] Example 3: Production of xylanase by fermentation using recombinant bacteria
[0064] 1. Recombinant bacterial fermentation and protein induction
[0065] The obtained Xynst or its mutant recombinant bacteria E.coli BL21 / pET28a-Xyn st A single colony was inoculated into 5 ml LB liquid medium with a final kanamycin concentration of 50 μg / ml and cultured at 150 rpm and 37°C for 12 h.
[0066] The culture solution was transferred to 1L fresh LB liquid medium at a 1% inoculum volume, cultured at 37°C until OD600 reached 0.6, and then IPTG was added to the medium at a final concentration of 0.8mM. The culture was continued at 25°C with shaking, and the induction lasted for 2-16h.
[0067] 2. Extraction and purification of recombinant xylanase protein
[0068] The fermentation broth was centrifuged at 6000 g for 10 min to collect the bacteria, which were resuspended in 40 ml of binding buffer (20 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole, pH 7.9), mixed well and then ultrasonically disrupted in an ice-water bath (300 W, ultrasonic for 3 s, rest for 3 s, 120 times).
[0069] Centrifuge at 8000rpm for 5min at 4℃, and the supernatant is the crude enzyme solution. The crude enzyme solution is added to the Ni-NTA affinity chromatography nickel column (gravity column), and after sufficient binding, it is washed with buffer A for 5-10 column volumes to remove impurities, and then eluted with buffer B (20mM, pH 7.4 Tris-HCl buffer, containing 500mM NaCl and 250mM imidazole) to obtain purified recombinant xylanase.
[0070] 3. Detection and quantification of recombinant xylanase protein
[0071] The purified product was analyzed by SDS-PAGE electrophoresis. Figure 2 As shown, lane 1: molecular weight marker; lane 2 / 6: E.coli BL21 / pET28a-Xyn st Uninduced lysate supernatant; Lanes 3-5: crude enzyme extracted from induced cell lysate; Lanes 7-9: Xyn purified by nickel column st The recombinant protein of its mutant W6F / Q7H was obtained. There was a specific protein of about 25 kD in the lane, which was consistent with the theoretical value. Scanning and analyzing SDS-PAGE showed that the protein content of the expressed xylanase reached more than 95% of the total protein after purification.
[0072] Bovine serum albumin was used as the standard protein, and the protein content was determined using a protein quantification kit based on the Lowry method.
[0073] Example 4: Determination of properties of recombinant bacterial xylanase
[0074] 1. Analysis of the enzyme activity of recombinant xylanase
[0075] The activity of xylanase was determined by detecting the amount of reducing sugar produced by dinitrosalicylic acid (DNS). The concentration of the purified enzyme protein was adjusted to 0.02 mg / mL, 50 μL of pure enzyme solution was added to a 2 mL centrifuge tube, and then 100 μL of 100 mg / mL beech xylan solution was added, and the mixture was hydrated to 1 mL. The mixture was reacted in a 65 °C water bath for 10 min, and immediately placed in a boiling water bath for 5 min to stop the enzymatic reaction. 0.2 mL of DNS reagent was added, and then placed in a boiling water bath for 10 min. After the reaction was completed, 0.8 mL of distilled water was added to a total volume of 2 mL. After mixing evenly, the absorbance was measured at 540 nm using an enzyme reader. One control and three parallels were set for each group of reactions. The absorbance was converted into the molar number of reducing sugars produced using the xylose standard curve. Under certain reaction conditions, the amount of enzyme that hydrolyzes xylan to release 1 μmol of xylose per minute is defined as 1 enzyme activity unit (U).
[0076] 2. Determination of the optimal pH and pH stability of recombinant xylanase
[0077] The optimum pH of the purified recombinant xylanase was determined by placing the purified enzyme solution in different 50mM buffers with 100mg / mL beech xylan as substrate at 55°C. The buffers used were: Na2HPO4-C6H8O7 buffer (pH3.0-8.0), Gly-NaOH buffer (pH 9.0–10.0), and Na2HPO4-NaOH buffer (pH 11.0-12.0). The pH stability was determined by keeping the enzyme solution in a water bath at 25°C for 0-8h in buffers of different pH values, and then determining the residual enzyme activity under the optimal condition (pH=9.0).
[0078] Figure 3A Indicates: Xylanase Xyn st The optimal pH for the mutant W6F / Q7H was 9.0, and it was relatively stable between pH 4.0 and 10.0. Figure 3B It shows that after 8h treatment in the optimal pH range, Xyn st The residual enzyme activity was above 50%, and the residual enzyme activity of the mutant W6F / Q7H was above 75%, which indicated that the enzyme, especially its mutant, had good pH stability.
[0079] 3. Determination of the optimum temperature and thermal stability of recombinant xylanase
[0080] The optimal temperature of the enzyme was determined by carrying out the enzymatic reaction at 30-90°C (pH=9.0). The thermal stability of the enzyme was evaluated by placing the same amount of enzyme solution in 50 mM Gly-NaOH buffer at 45-80°C for 0-360 min and then measuring the remaining enzyme activity under the optimal condition (pH=9.0).
[0081] The optimum temperature of enzyme reaction showed that Xyn st The optimum temperature is 55℃, and the optimum temperature of mutant W6F / Q7H is 65℃( Figure 4A , Figure 4B , Figure 4C At 55°C, Xyn st Activity slowly decreased; at 60℃, Xyn st The activity decreased by 80% within 5 minutes. The activity of mutant W6F / Q7H was very stable at 60℃ for 360 minutes. At 65℃, mutant W6F / Q7H could also retain 60% of its activity within 10 minutes.
[0082] 4. Determination of substrate selectivity and kinetic parameters of recombinant xylanase
[0083] Wheat straw xylan, bagasse xylan, beech xylan and corncob xylan with different final concentrations (1, 1.5, 2, 4, 6, 8 and 10 mg / mL) were used as substrates. The enzyme activity was determined under the optimal conditions (pH = 9.0, 55 / 65℃), and the corresponding reaction rate was calculated. The K was obtained using the Michaelis-Menten double reciprocal method. m Value and V max The results are shown in Table 1, indicating that Xyn st and its mutant W6F / Q7H all have substrate preference for beech xylan.
[0084] Table 1 Xylanase Xyn st The enzyme activity units and kinetic parameters of its mutant W6F / Q7H
[0085]
[0086] 5. Effect of NaCl on the activity and stability of recombinant xylanase
[0087] Effect of NaCl on recombinant enzyme activity: NaCl of different concentrations (0-4.0M) was added to the enzymatic reaction system to study its effect on enzyme activity. st The enzyme activities were determined at 50℃ and W6F / Q7H at 60℃ and pH 9.0 using beech xylan as substrate.
[0088] Effect of NaCl on the stability of recombinant enzyme: The enzyme solution was placed in a buffer solution containing 2M NaCl and placed at 25°C for different time periods (0-360 min). Then, the enzymatic reaction was carried out at pH 9.0 and 50-65°C to determine the residual activity.
[0089] The results showed that when the enzyme reaction system contained NaCl concentration within 0.25-3.0M, Xyn st and W6F / Q7H were significantly activated, and the maximum activity of the enzyme was detected in the presence of 2M NaCl, which was 396% and 810%, respectively; when the NaCl concentration was greater than 3M, the residual enzyme activity slowly decreased ( Figure 5A , Figure 5B In 2M NaCl solution, Xyn st At 50℃, the enzyme activity of W6F / Q7H did not decrease after being kept at 60℃ for 360min; at 65℃, the enzyme activity of Xyn st The enzyme activity loss was more than 90% within 10 min, but even after 240 min, the residual activity of W6F / Q7H was still comparable to that of Xyn st The initial activities were comparable, indicating that W6F / Q7H had good salt stability.
[0090] Example 5: Use of recombinant bacterial xylanase for XOS production
[0091] 0.5 mL (0.02 mg / mL) of Xyn st Or W6F / Q7H pure enzyme solution, 50℃ or 60℃, 180r / min water bath reaction, regular sampling and immediately put in boiling water bath for 5min to inactivate the enzyme, cool and centrifuge to take the supernatant for thin layer chromatography (TLC) and high performance liquid chromatography (HPLC) analysis, with xylose and xylooligosaccharides (xylobiose-xylohexose) as standards.
[0092] TLC analysis method: Use distilled water to prepare 100mL of 0.5% CMC solution, heat it appropriately and fully dissolve it, then use ultrasound (about 15 minutes) to remove bubbles; add 30g of thin layer silica gel powder to the solution, and use a mortar to fully grind the mixture. Spot the same volume of sample on the silica gel plate, the developing agent is a mixture of n-butanol, acetic acid and water (volume ratio is 2:1:1), and the color developer is a mixture of methanol and concentrated sulfuric acid (volume ratio of the two is 95:5). When the front edge of the developing agent reaches about two-thirds of the entire plate, take it out, dry it in an oven (80°C), take it out and cool it to room temperature, use a spray bottle to evenly spray the color developer on the back of the thin layer plate, dry it in an oven for about 20 minutes, and then observe the color.
[0093] like Fig. 6A , Figure 6B As shown, Xyn st TLC analysis of the hydrolysis products of bagasse xylan (A) and wheat straw xylan (B) by W6F / Q7H showed that the hydrolysis products mainly included xylobiose (X2), xylotriose (X3), xylotetrose (X4), and xylopentose (X5). After a short enzymatic hydrolysis time (0.5h), the enzymatic hydrolysis reaction tended to equilibrium and the total content of XOS no longer increased significantly. However, with the increase of enzymatic hydrolysis time, the xylobiose content in the W6F / Q7H enzymatic hydrolysate continued to increase, and no obvious xylose accumulation occurred.
[0094] HPLC analysis method: RID detector, detector temperature was 30°C, chromatographic column was amino column (4.6mm ID x150mm), mobile phase was 75% acetonitrile and 25% water by volume, flow rate was 1mL / min, column temperature was 30°C, and running time was 30min.
[0095] Xyn st The results of HPLC analysis of the enzymatic hydrolysis products of wheat straw xylan and sugarcane bagasse xylan by W6F / Q7H are shown in Table 2. In a short enzymatic hydrolysis time (within 0.5 h), the content of X3 in the hydrolyzate was the highest, followed by X2 and X4. st The conversion rate of wheat straw xylan by W6F / Q7H was 23.08%, which was a relative increase of 19.5%, and the XOS yield was increased by 0.381 mg / mL; the conversion rate of sugarcane bagasse xylan was 29.45%, which was a relative increase of 28.8%, and the XOS yield was increased by 0.659 mg / mL. No xylose was detected when sugarcane bagasse xylan was used as substrate, and the proportion of xylose was <1% when wheat straw xylan was used as substrate, so the enzyme is suitable for producing high-quality XOS from agricultural waste.
[0096] Table 2 HPLC analysis of hydrolyzate at 0.5 h of enzymatic reaction
[0097]
[0098] The endoxylanase of the present invention has high specific activity, good acid-base stability, and is enhanced by high salt, and has good application prospects in high-salt environments, such as high-salt food processing, aquatic feed production, saline wastewater treatment, and saline-alkali land fertility improvement.
[0099] The above is only a specific implementation of the present application, but the protection scope of the present application is not limited thereto. Any changes or substitutions that can be easily thought of by a person skilled in the art within the technical scope disclosed in the present application should be included in the protection scope of the present application. Therefore, the protection scope of the present application shall be based on the protection scope of the claims.
Claims
1. A high-activity halophilic xylanase, which is a protein of the following (a) or (b): (a) a protein consisting of the amino acid sequence shown in SEQ ID NO.1; (b) A derivative protein having a higher xylanase activity than the protein in (a) by replacing and / or deleting and / or adding one or more amino acid residues of the amino acid residues shown in SEQ ID NO.
1.
2. A gene encoding the high-activity halophilic xylanase according to claim 1.
3. The coding gene according to claim 2, characterized in that: The nucleotide sequence of the coding gene is the DNA molecule shown in SEQ ID NO.
2.
4. The coding gene according to claim 2, characterized in that: The nucleotide identity of the coding gene and the DNA molecule shown in SEQ ID NO.2 is greater than 90%. A recombinant vector comprising the coding gene according to claim 2. A transgenic cell line comprising the coding gene according to claim 2.
7. A recombinant bacterium comprising the coding gene according to claim 2.
8. Use of the high-activity halophilic xylanase according to claim 1, the encoding gene according to any one of claims 2 to 4, the recombinant vector according to claim 5, the transgenic cell line according to claim 6, and the recombinant bacteria according to claim 7 in hydrolyzing xylan.
9. The use according to claim 8, characterized in that: The xylan hydrolysis reaction was carried out in the presence of 0.25-3 M NaCl.
